Characteristic morphology and immunohistochemical patterns of clear cell papillary renal cell tumours may be observed in renal cell carcinomas, a critical pitfall in renal biopsy cytopathology

被引:2
作者
Lin, Xiaoqi [1 ,2 ]
机构
[1] Northwestern Univ, Dept Pathol, Chicago, IL USA
[2] Northwestern Univ, Northwestern Mem Hosp, Feinberg Sch Med, Dept Pathol, 251 E Huron St,Galter Pavilion 7-132F, Chicago, IL 60611 USA
关键词
clear cell papillary renal cell tumour; core needle biopsy; cytopathology; immunohistochemistry; molecular test; renal cell carcinoma; touch preparation; FEATURES;
D O I
10.1111/cyt.13384
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
BackgroundClear cell papillary renal cell tumour (CCPRCT) was renamed from previous clear cell papillary renal cell carcinoma (CCPRCC) in the latest WHO Classification of Tumours. It is essential to differentiate RCC from CCPRCT in renal mass biopsies (RMB).DesignRMB cases with subsequent resections were reviewed. The pathology reports and pertinent clinical information were recorded.ResultsFifteen cases displaying either CCPRCT morphology (20% diffuse, 67% focal) or immunohistochemical patterns (cup-like CA9: 20% diffuse, 47% focal; CK7: 33% diffuse, 40% focal) were identified. One case was positive for TFE3. TSC mutation was identified in one case. Both cases exhibited both CCPRCT morphology and immunohistochemical patterns for CA9 and CK7, with focal high-grade nuclei. RMB diagnoses were as follows: 6 (40%) as CCRCC, 2 (13%) as CCPRCT, 2 (13%) as CCRCC versus CCPRCT, 2 (13%) as CCRCC versus PRCC, 1 (7%) as RCC with TSC mutation versus CCPRCT, 1 (7%) as TFE3-rearranged RCC versus PRCC, and 1 (7%) as cyst with low-grade atypia. 71% of patients underwent nephrectomy, 21% received systemic treatment for stage 4 RCCs, and 7% with ablation for small renal mass (1.6 cm) with low-grade CCRCC.ConclusionsOur study highlights that morphologic and immunochemical features of CCPRCT may be present in RCCs, including RCC-TFE3 expression and TSC-associated RCC, a critical pitfall to misdiagnose aggressive RCC as indolent CCPRCT and result in undertreatment. Careful examination of morphology and immunostains for CA9, CK7, and TFE3, as well as molecular tests, is crucial for distinguishing aggressive RCC from indolent CCPRCT. The characteristic morphology and immunohistochemical patterns observed in CCPRCT can also manifest in RCC. It is crucial to distinguish indolent CCPRCT from more biologically aggressive forms of RCC for the improvement of patients' management.image
引用
收藏
页码:481 / 487
页数:7
相关论文
共 16 条
  • [1] Xanthomatous Giant Cell Renal Cell Carcinoma Another Morphologic Form of TSC-associated Renal Cell Carcinoma
    Argani, Pedram
    Matoso, Andres
    Pallavajjalla, Aparna
    Haley, Lisa
    Tseh-Lin, Ming
    Ng, Jessica
    Chow, C. W.
    Lotan, Tamara
    Mehra, Rohit
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2022, 46 (11) : 1554 - 1561
  • [2] Board WCTE, 2022, WHO classification of tumours series
  • [3] Cheville J., 2022, WHO CLASSIFICATION T, P61
  • [4] Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas
    Classe, Marion
    Malouf, Gabriel G.
    Su, Xiaoping
    Yao, Hui
    Thompson, Erika J.
    Doss, Denaha J.
    Gregoire, Valerie
    Lenobin, Julien
    Fantoni, Jean-Christophe
    Sudour-Bonnange, Helene
    Khayat, David
    Aubert, Sebastien
    Tannir, Nizar M.
    Leroy, Xavier
    [J]. HISTOPATHOLOGY, 2017, 70 (07) : 1089 - 1097
  • [5] A Sarcomatoid Renal Cell Carcinoma with Clear Cell Papillary-Like Primary Tumor and Lymph Node Metastasis: A Diagnostic Conundrum
    Demko, Nadine
    Glennon, Kate, I
    Arseneault, Madeleine
    Lach, Katherine
    Nishimura, Tamiko
    Tanguay, Simon
    Riazalhosseini, Yasser
    Brimo, Fadi
    [J]. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2023, 31 (05) : 890 - 895
  • [6] Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma A Clinicopathologic Study of 37 Cases From a Single Institution
    Dhakal, Hari P.
    McKenney, Jesse K.
    Khor, Li Yan
    Reynolds, Jordan P.
    Magi-Galluzzi, Cristina
    Przybycin, Christopher G.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (02) : 141 - 154
  • [7] CLINICAL EFFECTS OF MND-19 (INOSIPLEX) ON SUBACUTE SCLEROSING PANENCEPHALITIS - A MULTIINSTITUTIONAL COLLABORATIVE STUDY
    FUKUYAMA, Y
    NIHEI, K
    MATSUMOTO, S
    EBINA, T
    KAMOSHITA, S
    SATO, T
    ARIMA, M
    YABUUCHI, H
    UEDA, S
    OHTAHARA, S
    TAKESHITA, K
    KUROKAWA, T
    ISHIDA, N
    OKUNO, Y
    TATEISHI, J
    SAKUMA, A
    [J]. BRAIN & DEVELOPMENT, 1987, 9 (03) : 270 - 282
  • [8] Clear cell papillary renal cell carcinoma - A distinct histopathologic and molecular genetic entity
    Gobbo, Stefano
    Eble, John N.
    Grignon, David J.
    Martignoni, Guido
    MacLennan, Gregory T.
    Shah, Rajal B.
    Zhang, Shaobo
    Brunelli, Matteo
    Cheng, Liang
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008, 32 (08) : 1239 - 1245
  • [9] Renal cell carcinoma with leiomyomatous stroma in tuberous sclerosis complex: a distinct entity
    Gournay, Marjorie
    Dugay, Frederic
    Belaud-Rotureau, Marc-Antoine
    Peyronnet, Benoit
    Mathieu, Romain
    Verhoest, Gregory
    Bensalah, Karim
    Odent, Sylvie
    Denizeau, Philippe
    Vigneau, Cecile
    Morini, Aurelien
    Rioux-Leclercq, Nathalie
    Kammerer-Jacquet, Solene-Florence
    [J]. VIRCHOWS ARCHIV, 2021, 478 (04) : 793 - 799
  • [10] Cytomorphologic analysis of clear cell papillary renal cell carcinoma: Distinguishing diagnostic features
    Griffin, Brannan B.
    Lin, Xiaoqi
    [J]. CANCER CYTOPATHOLOGY, 2021, 129 (03) : 192 - 203